Peri-Implantitis and Peri-implant Mucositis
15
0
3
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (15)
Evaluation of Implantoplasty in the Treatment of Peri-Implantitis.
The Use of Adjunct Oxygen High-Level Laser Therapy on the Clinical and Microbiological Outcomes of Peri-implant Disease
Longitudinal Evaluation of Regenerative Treatment of Peri-implantitis Assited by Er,Cr:YSGG Laser: up to 10 Years Follow-up
Genomic and Proteomic Analyses of Apoptosis Mechanisms in Diseased Peri-implant Tissue
Peri-implant Vitamin D and Cathelicidin (LL-37) Levels
Analysis of HIF-1α, MDA, and GPX4 in Peri-Implant Crevicular Fluid
Monitoring of Implant Diseases: Diagnosis and Monitoring with AMMP-8 Test Technology
Evaluation of Hydrogel Application in the Treatment of Periodontitis and Peri-implantitis
SPiT-frequency II_Peri-implantitis
SPiT-frequency I_Peri-implant Mucositis
Effect of Different Non-surgical Treatment Approaches of Peri-implantitis
Effectiveness of Zirconia Glaze Removal and Polish in the Treatment of Peri-implant Mucositis
Risk Assessment of Proximal Contact Loss Between Implant-supported Prostheses and Adjacent Teeth.
Salivary Minerals in Patients With Peri-implantitis
Non Surgical Treatment of Periimplantitis